Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD

NANot yet recruitingINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

September 30, 2025

Conditions

Graft-versus-host-diseaseGraft Versus Host Disease, ChronicStem Cell Transplant ComplicationsHematological MalignancyHematologic Cancer

Interventions

OTHER

Physical therapy

Health education sessions and combined therapeutic exercise sessions, based on muscular strength training and cardiorespiratory endurance.

Trial Locations (1)

University of Seville; Manuel Siurot Avenue, no number, Seville

All Listed Sponsors

lead

University of Seville

OTHER

NCT06279585 - Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD | Biotech Hunter | Biotech Hunter